G-MedTech Weekly Live | April 21–27, 2025

Updated in real-time, this page delivers the week’s key global medtech developments, including product approvals, technology breakthroughs, and strategic moves such as M&A, partnerships, and funding activity.

战略发展

Olympus appoints former Medtronic executive Bob White as new CEO effective June 1, 2025, to lead the company’s MedTech transformation efforts.

Sun Yat-sen University’s Seventh Affiliated Hospital (中山大学附属第七医院) partners with Huawei, United Imaging, and Lianxin to establish a Smart Medical Innovation Center, deploying a 10P AI computing platform to enable full-process intelligent diagnostics and build a national smart hospital benchmark.

Medtronic partners with Dragonfly™ Endoscopy to distribute its innovative pancreaticobiliary system in the US, featuring a 42% larger working channel for improved stone clearance and biopsy sampling in cholangioscopy procedures.

HeartBeam partners with AccurKardia to integrate FDA-cleared AccurECG™ arrhythmia analysis onto its credit card-sized 3D ECG device, enhancing remote cardiac monitoring capabilities for faster diagnosis.

Cirtec Medical expands Costa Rica operations with 50,000+ sq ft facility to boost manufacturing capacity for neuromodulation and cardiac devices, enhancing vertical integration and time-to-market for medtech partners.

Peking University Third Hospital (北京大学第三医院) and Hong Kong PolyU establish joint lab for AI-powered early cancer detection and minimally invasive therapy, launching a 3-year research initiative with sealed ‘time capsule’ commitments.

Ypsomed sells its diabetes care business to TecMed AG for up to CHF 420 million, shifting focus to subcutaneous self-injection systems while TecMed consolidates insulin pump technologies including mylife Loop and CamAPS FX.

Cook Medical partners with Mendaera to integrate its EchoTip needle technology with Mendaera’s handheld robotic platform, enhancing precision in urological needle-based interventions.

School of Life Sciences, East China Normal University (华东师范大学) and Roche Diagnostics establish joint genomics lab to advance precision medicine research, integrating Roche’s Digital LightCycler® PCR and NGS platforms with academic expertise in gene editing and tumor biology.

Sonus Microsystems partners with Providence Health Care Ventures to develop its wearable cardiac ultrasound patch, using polymer MEMS technology for remote heart failure monitoring and AI-driven diagnostics.

CardioOne partners with Catalyst MedTech to launch advanced cardiac imaging centers in New Jersey and Philadelphia, offering PET-CT and CT angiography services to independent cardiology practices by late 2025.

Zimmer Biomet completes its acquisition of Paragon 28, strengthening its position in the high-growth foot and ankle orthopedic segment through Paragon’s specialized technology platform and dedicated commercial channel.

Neusoft Medical partners with Beijing Tiantan Hospital to launch a national 3.0T MRI promotion initiative, advancing China’s domestically-developed high-end medical equipment for broader clinical adoption.

投融资

Shenzhen-based Synaire Medical (新奈医疗) completes tens of millions of RMB angel round (led by HG Capital) to develop AI-powered home ventilators with physiological closed-loop control and modular design, targeting FDA/CE clearance by 2026.

Core Medical (Chinese Name: 核心医疗) secures $100M+ Series D funding – China’s largest medtech financing in 2025 – to advance its Corheart®6 LVAD (46% domestic share) and DuoCor® BIVAD systems, accelerating global expansion in heart failure treatment.

Easy-Flow Medical (Chinese Name: 畅德医疗) secures over RMB 100 million (US$14M) in Series A+ funding led by Shanghai Healthcare Capital to advance its peripheral vascular product pipeline, including its EF-Lumber® drug-eluting stent currently in clinical trials under China’s accelerated review pathway.

Biolinq raises $100M Series C funding to advance its intradermal glucose biosensor for Type 2 diabetes management, following pivotal trial completion and pending US regulatory submission.

Chinese vascular robotics pioneer Aopeng Medical (Chinese Name: 奥朋医疗) secures nearly RMB 100 million (US$14M) in Series C funding to advance AI-powered interventional surgical robots, having achieved three world-first robotic procedures in neurovascular and aortic surgeries.

Hangzhou Meiyin Intelligent (Chinese Name: 每因智能) secures over RMB 10 million in seed funding to develop its AI disease risk prediction platform, which uses its DP-LLM model to analyze health data and enable personalized insurance solutions in China’s healthcare market.

Field Medical secures $40M Series A funding to advance its pulsed field ablation system for ventricular tachycardia, with clinical trials underway for VT and atrial fibrillation applications.

Shanghai-based United InnoMed (Chinese Name: 合源医疗) secures over RMB 100 million (US$14M) in funding to advance its innovative implantable heart failure (HF) management systems, including chronic HF ‘therapy+diagnosis’ implants and acute HF electrical circulatory support devices entering clinical trials.

产品与技术

Shanghai Renji Hospital (上海交通大学医学院附属仁济医院) deploys the world’s first integrated CT circular linear accelerator, uLinac HalosTx developed by United Imaging, featuring 50% faster treatment times and real-time adaptive radiotherapy capabilities for precision cancer treatment.

Edwards Lifesciences launches MITRIS RESILIA dry mitral valve in China, featuring anti-calcification technology for improved durability in minimally invasive procedures. The NMPA-approved valve addresses China’s growing valvular disease burden with enhanced lifespan management solutions.

SinoPharm-GE Medical Imaging (国药通用（深圳）医疗影像有限公司) launches its first CT product – the Kunling 16-slice CT – with NMPA approval, targeting primary healthcare needs in China with cost-effective imaging solutions.

FDA approves Medtronic’s OmniaSecure™ lead – the world’s smallest (1.6mm) defibrillation lead for right ventricle placement. Clinical study results show 100% defibrillation success when investigationally placed in left bundle branch area for physiologic pacing.

ClearPoint Neuro launches Navigation Software 3.0, enabling iCT-guided brain procedures in standard ORs while maintaining MRI-level precision for DBS and other stereotactic surgeries.

LEM Surgical receives FDA clearance for its Dynamis Robotic Surgical System, a multi-arm robotic platform for spine surgery featuring real-time imaging and adaptable instrumentation compatibility.

FDA clears Clarius Prostate AI – the first AI-powered prostate measurement tool for handheld ultrasound scanners. The semi-automatic tool provides instant volume calculations during exams, helping physicians assess BPH and prostate cancer faster without specialist referrals.

Medtronic adds Retia Medical’s Argos™ cardiac output monitor to its Acute Care portfolio, offering advanced multi-beat hemodynamic analysis for critical care. The non-invasive device aims to reduce ICU stays by enabling earlier intervention.

Medtronic submits FDA 510(k) applications for its MiniMed™ 780G pump and SmartGuard™ algorithm to enable interoperability with Abbott’s advanced CGM platform in automated insulin delivery systems.

Peking University Third Hospital (北京大学第三医院) launches ‘SanYuan LingZhi’ (三院灵智) AI system powered by DeepSeek, integrating diagnostic support, surgical planning and research tools across clinical workflows with 90% efficiency gains in documentation.

Wisonic Medical (Chinese Name: 华声医疗) integrates DeepSeek AI with its ultrasound QC platform, enabling real-time image analysis, automated reporting, and 5G-enabled remote quality control for standardized diagnostic workflows.

MicroPort® MedBot™’s Toumai® Endoscopic Telesurgery System becomes the world’s first NMPA-approved remote surgical robot, enabling thoraco-abdominal procedures across 103 countries with <150ms latency.

West China Hospital’s PROSTYLE A® becomes the world’s first dry-stored TAVR valve system approved by China NMPA, eliminating glutaraldehyde preservation to improve biocompatibility and simplify implantation for aortic stenosis patients.

GeneoDx Biotech (Chinese Name: 捷诺生物) receives NMPA approval for China’s first multiplex PCR test detecting syphilis and HSV-I/II simultaneously, expanding its reproductive pathogen diagnostics portfolio.

Baebies receives FDA Breakthrough Device Designation for its FINDER® Anti-Factor Xa test, the first point-of-care heparin monitoring assay delivering results in under 15 minutes from 50µL whole blood.

CereVasc receives FDA Breakthrough Device Designation for its eShunt® System in pediatric hydrocephalus patients aged 12+, supported by clinical data showing 67% anatomical feasibility for the minimally invasive endovascular treatment.

Cortechs.ai receives Health Canada approval for its AI-powered medical imaging suite including NeuroQuant for brain MRI analysis and OnQ Prostate for cancer evaluation, expanding its North American market presence.

Labcorp expands precision oncology portfolio with two liquid biopsy solutions: Plasma Detect for colon cancer recurrence risk assessment and FDA-authorized PGDx elio plasma focus Dx for pan-solid tumor treatment selection.

Mursla Bio receives FDA Breakthrough Device Designation for EvoLiver blood test detecting early-stage liver cancer via organ-specific extracellular vesicles, demonstrating 86% sensitivity in clinical trials.

ARUP Laboratories launches pTau 217 blood test for Alzheimer’s detection in patients 60+, validated against amyloid-PET imaging data from Lilly’s TRAILBLAZER-ALZ 2 trial as a less invasive diagnostic alternative.

Epiminder receives FDA De Novo approval for Minder®, the first implantable continuous EEG monitor for epilepsy patients, enabling months-long brain activity tracking compared to traditional days-limited EEG systems.

Veravas launches VeraBIND™ Tau blood test for Alzheimer’s detection with 96% sensitivity and 90% specificity, offering non-invasive alternative to PET imaging and spinal taps for tau pathology assessment.

Vivasure Medical receives CE Mark for PerQseal Elite, the first fully absorbable sutureless vascular closure system for large-bore procedures like TAVR/EVAR, eliminating permanent implants and pre-procedure steps.

Pixee Medical receives FDA 510(k) clearance for its Knee+ NexSight AR navigation system for total knee replacements in ASCs, offering robotic precision without preoperative imaging or capital equipment costs.

Validic and Tenovi integrate cellular-connected RPM solutions with EHR workflows, enabling automated medical device data capture for remote patient monitoring without Wi-Fi/smartphone dependency.

Nihon Kohden launches second-gen Live View Panel Pro™ for remote neurology care, featuring real-time monitoring, two-way communication and integrated EEG/PSG/IOM data to improve outcomes and reduce patient transfers.

Fujifilm India launches ELUXEO 8000 therapeutic endoscopy system featuring advanced imaging technologies (ACI/TNR/E-DRIP) for precise minimally invasive procedures, now available beyond Japan/Europe markets.

BD launches its HemoSphere Alta™ hemodynamic monitoring platform with AI-driven clinical decision support, featuring the first Cerebral Autoregulation Index to predict blood flow stability and Hypotension Prediction Index software to anticipate low blood pressure events during procedures.

Broncus Medical’s (堃博医疗) BroncAblate® receives China NMPA approval as the world’s first natural orifice RF ablation device for lung cancer, addressing key technical challenges in pulmonary tumor ablation through bronchoscopic delivery.